Does SARILUMAB Cause Disseminated intravascular coagulation? 10 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Disseminated intravascular coagulation have been filed in association with SARILUMAB (KEVZARA). This represents 0.1% of all adverse event reports for SARILUMAB.
10
Reports of Disseminated intravascular coagulation with SARILUMAB
0.1%
of all SARILUMAB reports
4
Deaths
4
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From SARILUMAB?
Of the 10 reports, 4 (40.0%) resulted in death, 4 (40.0%) required hospitalization, and 5 (50.0%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARILUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which SARILUMAB Alternatives Have Lower Disseminated intravascular coagulation Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE